KLA stock slides after-hours as chip gear names cool off; India R&D expansion in focus

KLA stock slides after-hours as chip gear names cool off; India R&D expansion in focus

New York, Jan 7, 2026, 19:14 EST — After-hours KLA Corp shares fell about 2.5% to $1,359.69 in after-hours trading on Wednesday, tracking a late-day pullback in semiconductor equipment stocks. Applied Materials, Lam Research and ASML also ended lower as the S&P 500 slipped and investors rotated back toward a narrow set of mega-cap AI names that lifted the Nasdaq, a Reuters report showed. Reuters That matters for KLA because it sits in the middle of chip-factory spending: it sells process-control tools that inspect wafers for defects and help chipmakers keep yields up. When the market’s mood swings on rates
Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus

Credo (CRDO) stock jumps 6% after-hours after insider filings; Needham conference is next focus

New York, January 7, 2026, 18:57 (EST) — After-hours Credo Technology Group Holding Ltd shares rose about 6% to $141 in after-hours trading on Wednesday, after swinging between $124.85 and $143.14 in the regular session. The Nasdaq-listed stock is about 6% below its 52-week high of $150.76. The move matters because Credo sits in the middle of the AI data-center buildout trade — a part of semiconductors where sentiment can turn on small scraps of information. When a high-beta stock like this whipsaws in a day, investors usually go looking for a trigger, even if it is just positioning. One
Dell stock slides 3% after CES XPS comeback as memory costs loom

Dell stock slides 3% after CES XPS comeback as memory costs loom

NEW YORK, Jan 7, 2026, 19:14 EST — After-hours Dell Technologies Inc. (DELL) shares fell 3.1% to $120.07 in after-hours trade on Wednesday, down $3.87 from the prior close after touching a session low of $118.75. About 10.3 million shares changed hands; the S&P 500 tracker SPY slipped 0.3% while the Nasdaq 100 tracker QQQ edged up 0.1%. The drop lands as Dell tries to reset its consumer and gaming story at the CES trade show and investors argue over a familiar squeeze: higher parts costs, soft demand, and uneven pricing power in PCs. At CES in Las Vegas, Dell
Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

New York, Jan 7, 2026, 18:54 EST — After-hours Thermo Fisher Scientific shares slipped about 0.6% in after-hours trading on Wednesday to $617.15, after swinging between $611.93 and $626.40 during the session. The dip comes with the stock sitting near recent highs and the calendar tightening. Investors are staring at next week’s J.P. Morgan Healthcare Conference and Thermo Fisher’s quarterly results later this month, looking for a clean read on demand and the 2026 setup. On Tuesday, the company said it enrolled the first patient in a new PPD CorEvitas obesity registry, a prospective study meant to collect “real-world evidence”
UK water watchdog says Tunbridge Wells outage was “no surprise” as South East Water boss faces MPs

UK water watchdog says Tunbridge Wells outage was “no surprise” as South East Water boss faces MPs

LONDON, Jan 8, 2026, 00:03 GMT Britain’s drinking water watchdog told lawmakers this week that South East Water’s Pembury treatment works showed weeks of worsening performance before supplies to Tunbridge Wells failed, leaving the site “flying blind” without proper electronic monitoring, and that the incident “should not have been a surprise.” UK Parliament Committees The warning comes as MPs take evidence for an inquiry into reforming the water sector, after residents were told on Nov. 29 that tap water was unsafe for drinking and other uses and that advice remained in place until Dec. 12, parliament’s committees service said. UK
8 January 2026
Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

Merck (MRK) stock slips after-hours as CDC backs one-dose HPV shot; Cidara deal closes

New York, Jan 7, 2026, 18:52 EST — After-hours Merck & Co (MRK.N) shares edged down in after-hours trading on Wednesday after U.S. health officials updated the childhood immunization schedule and moved to a single dose for the human papillomavirus (HPV) vaccine, a change that could pressure demand for Merck’s Gardasil shot. The stock was down about 0.2% at $108.60, after trading between $107.99 and $111.42 in the regular session. HHS.gov The CDC move lands at an awkward moment for Merck, which relies on Gardasil as its biggest vaccine franchise and a key growth lever alongside cancer drug Keytruda. Jefferies
American Airlines stock rises as free Wi‑Fi rollout meets softer U.S. fines stance

American Airlines stock rises as free Wi‑Fi rollout meets softer U.S. fines stance

New York, Jan 7, 2026, 18:49 EST — After-hours American Airlines Group Inc shares rose about 2% to $15.99 on Wednesday, after trading between $15.65 and $16.50. The gains come a day after the carrier said it will launch free in-flight Wi‑Fi for AAdvantage loyalty members in a sponsorship deal with AT&T. Airlines have leaned harder on perks like onboard internet as they fight for higher-spending, repeat customers. Reuters American’s move stood out in a mixed session for the group. Delta and United fell about 0.8% each, while the U.S. Global Jets ETF slipped roughly 0.4%; oil eased about 1%,
Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead

Seagate stock (STX) slides after CES-fueled rally cools; earnings date ahead

NEW YORK, Jan 7, 2026, 18:50 EST — After-hours Seagate Technology Holdings plc (STX) shares fell about 6.7% to $308.26 in after-hours trading on Wednesday, trimming a sharp run that had pushed the data-storage maker to fresh highs earlier in the week. The stock traded between $299.04 and $330.42 during the session. The pullback tracked a wider cooling in memory and storage names after a fast start to 2026, even as investors rotated back into heavyweight AI stocks. “Buy tech and forget about it” has been the playbook again, said Jake Dollarhide, chief executive of Longbow Asset Management. Reuters On
First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

First Solar stock slides 10% on Jefferies downgrade as 2026 orders come into focus

New York, January 7, 2026, 18:48 (EST) — After-hours Shares of First Solar (FSLR) fell 10.3% to $241.11 on Wednesday after Jefferies downgraded the U.S. solar panel maker to “hold” from “buy” and cut its price target to $260 from $269. The brokerage cited “limited booking visibility” for 2026 and said a hoped-for “S232” tailwind — shorthand for potential Section 232 duties that can be imposed after a Commerce Department national-security investigation — could “underwhelm investor expectations,” flagging possible carve-outs for Germany and developers moving ahead of any levies. The stock opened at $254.02 and touched $239.26 at its low;
Procter & Gamble stock keeps sliding — what investors are watching before earnings

Procter & Gamble stock keeps sliding — what investors are watching before earnings

New York, Jan 7, 2026, 18:37 ET — After-hours Procter & Gamble (PG.N) fell 1.4% to $138.04 at Wednesday’s close. It touched $137.64 earlier in the session. P&G is a bellwether for consumer staples, and the steady slide is landing just as traders brace for earnings season and a messy macro tape. The S&P 500 ended lower while the Nasdaq held up on a renewed tilt toward AI-linked stocks; “Investors have come into 2026 with a similar playbook to last year: Buy tech and forget about it,” said Jake Dollarhide, chief executive officer of Longbow Asset Management. The S&P 500
AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

AbbVie stock slips after hours after denying Revolution Medicines talks, trims 2025 profit view

New York, Jan 7, 2026, 18:35 EST — After-hours AbbVie (ABBV.N) shares were down about 1% at $231.11 in after-hours trading on Wednesday after the drugmaker denied a Wall Street Journal report that it was in advanced talks to buy cancer-drug developer Revolution Medicines (RVMD.O), saying it “is not in discussions with Revolution Medicines.” The stock had closed up 4.2% at $233.42, while Revolution shares slid 11.5% late after jumping nearly 30% earlier, with the report pointing to a valuation around $20 billion. AbbVie has spent more than $20 billion on acquisitions since 2023 as its former blockbuster Humira lost
Caterpillar stock drops more than 4% after-hours as CEO chair shift and AI push grab focus

Caterpillar stock drops more than 4% after-hours as CEO chair shift and AI push grab focus

New York, January 7, 2026, 18:37 EST — After-hours Caterpillar Inc shares fell 4.3% in after-hours trading on Wednesday to $596.52. The stock briefly dipped to $595.84 earlier in the session; after-hours trading is the stretch after the closing bell when liquidity can be thinner. The drop tracked a softer tone in U.S. equities, with the Dow down 0.94% and the S&P 500 off 0.34% as investors digested fresh labour-market readings and looked ahead to Friday’s government payrolls report. Caterpillar, a major supplier of construction and mining equipment and industrial engines, often trades as a read-through on big-ticket capital spending.

Stock Market Today

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop